Notch3 overexpression associates with poor prognosis in human non-small-cell lung cancer

Ye, Yuan-zi; Zhang, Zhi-hong; Fan, Xiao-yun; Xu, Xiao-lan; Chen, Mei-li; Chang, Bo-wen; Zhang, Yan-bei
June 2013
Medical Oncology;Jun2013, Vol. 30 Issue 2, p1
Academic Journal
No abstract available.


Related Articles

  • Association between single nucleotide polymorphisms of NOTCH signaling pathway-related genes and the prognosis of NSCLC. Xu, Qiuping; Lin, Danhua; Li, Xu; Xiao, Rendong; Liu, Zhiqiang; Xiong, Weimin; Cai, Lin; He, Fei // Cancer Management & Research;Jul2019, Vol. 11, p6895 

    Highlights from the article: Prognosis, interaction, non-small-cell lung cancer, single-nucleotide polymorphism, NOTCH signaling pathway.

  • Meta-analysis reveals the correlation of Notch signaling with non-small cell lung cancer progression and prognosis. Yuan, Xun; Wu, Hua; Xu, Hanxiao; Han, Na; Chu, Qian; Yu, Shiying; Chen, Yuan; Wu, Kongming // Scientific Reports;5/22/2015, p10338 

    Various studies have assessed the clinicopathological and prognostic value of Notch1 and Notch3 expression in Non-small cell lung cancer (NSCLC), but their results remain controversial. This meta-analysis was conducted to address the above issues by using a total of 19 studies involving 3663...

  • Expression and prognostic value of E2F activators in NSCLC and subtypes: a research based on bioinformatics analysis. Gao, Zhaojia; Shi, Run; Yuan, Kai; Wang, Yong // Tumor Biology (Springer Science & Business Media B.V.);Nov2016, Vol. 37 Issue 11, p14979 

    E2F activators (E2F1-3) codify a family of transcription factors (TFs) in higher eukaryotes. E2F activators are involved in the cell cycle regulation and synthesis of DNA in mammalian cells, and their overexpression has been detected in many human cancers. However, their clinical significance...

  • Regulation of chemosensitivity and migration by clusterin in non-small cell lung cancer cells. Cheng, Ching-Yuan; Cherng, Shur-Hueih; Wu, Wen-Jun; Yang, Tsung-Ying; Huang, Xin-Yi; Liao, Fu-Tien; Wu, Ming-Fang; Sheu, Gwo-Tarng // Cancer Chemotherapy & Pharmacology;Jan2012, Vol. 69 Issue 1, p145 

    Purpose: In terms of drug resistance, cancer cells usually benefit from high clusterin (CLU) expression on chemotherapy. In contrast, CLU expression has been found to be a favorable prognostic factor in lung cancer patients. The aims of this study are to determine the association between CLU...

  • EGFR Signaling and Drug Discovery. Lurje, Georg; Lenz, Heinz-Josef // Oncology;Feb2010, Vol. 77 Issue 6, p400 

    Dysregulation of human epidermal growth factor receptor (ErbB/HER) pathways by over-expression or constitutive activation can promote tumor processes including angiogenesis and metastasis and is associated with poor prognosis in many human malignancies. In addition to cancer, ErbB signaling has...

  • Foxm1 transcription factor is required for the initiation of lung tumorigenesis by oncogenic KrasG12D. Wang, I-C; Ustiyan, V; Zhang, Y; Cai, Y; Kalin, T V; Kalinichenko, V V // Oncogene;11/13/2014, Vol. 33 Issue 46, p5391 

    Lung cancer is the leading cause of deaths in cancer patients in the United States. Identification of new molecular targets is clearly needed to improve therapeutic outcomes of this devastating human disease. Activating mutations in K-Ras oncogene and increased expression of FOXM1 protein are...

  • Chromosome 19 translocation, overexpression of Notch3, and human lung cancer. Dang, Thao P.; Gazdar, Adi F.; Dang, T P; Gazdar, A F; Virmani, A K; Sepetavec, T; Hande, K R; Minna, J D; Roberts, J R; Carbone, D P // JNCI: Journal of the National Cancer Institute;08/16/2000, Vol. 92 Issue 16, p1355 

    Examines chromosomal translocation caused by genetic overexpression in human lung cancer. Genetic abnormalities in lung carcinomas; Function of Nothch3, a mammalian homologue of the Drosophila Notch receptor; Identification of somatically acquired translocation; Implication of Notch3...

  • HIF-1α and NOTCH signaling in ductal and lobular carcinomas of the breast. Ercan, Cigdem; Vermeulen, Jeroen; Hoefnagel, Laurien; Bult, Peter; Groep, Petra; Wall, Elsken; Diest, Paul // Cellular Oncology (2211-3428);Dec2012, Vol. 35 Issue 6, p435 

    Background: NOTCH signaling is involved in every step of metazoan development and maintenance of adult tissue homeostasis. It is frequently deregulated by mutations and overexpression in different cancer types including solid tumors such as breast cancer. Another common feature of solid tumors...

  • Hes1 Increases the Invasion Ability of Colorectal Cancer Cells via the STAT3-MMP14 Pathway. Weng, MT; Tsao, PN; Lin, HL; Tung, CC; Change, MC; Chang, YT; Wong, JM; Wei, SC // PLoS ONE;12/9/2015, Vol. 10 Issue 12, p1 

    The Notch pathway contributes to self-renewal of tumor-initiating cell and inhibition of normal colonic epithelial cell differentiation. Deregulated expression of Notch1 and Jagged1 is observed in colorectal cancer. Hairy/enhancer of split (HES) family, the most characterized targets of Notch,...

  • Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer. Passaro, Antonio; Alesini, Daniele; Pochesci, Alessia; Cortesi, Enrico // Anti-Cancer Agents in Medicinal Chemistry;Jun2014, Vol. 14 Issue 5, p646 

    Erlotinib and gefitinib are tyrosine kinase inhibitors (TKI) associated with the EGFR, which is involved in cell proliferation, growth, migration, invasion and survival, and has been found to be overexpressed in non-small-cell lung cancer. Erlotinib was the first target agent approved for the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics